1-4 of 4
Kai Uwe Chow
Close
Sort by
Journal Articles

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Idelalisib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Nadine Kutsch, MD, Christian Pallasch, Thomas Decker, Holger Hebart, Kai Uwe Chow, Ullrich Graeven, Jens Kisro, Alexander Kroeber, Eugen Tausch, Clemens-Martin Wendtner, Michael J. Eckart, Stephan Stilgenbauer, Xi Huang, Juliane M. Jürgensmeier, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3047.
https://doi.org/10.1182/blood-2019-131025
Published: 2019
Journal Articles

Prostate-Apoptosis-Response-Gene-4 Increases Sensitivity to TRAIL-Induced Apoptosis.

Simone Boehrer, Daniel Nowak, Elena Puccetti, Martin Ruthardt, Nicole Sattler, Bettina Trepohl, Bernd Schneider, Dieter Hoelzer, Paris S. Mitrou, Kai Uwe Chow
Journal: Blood
Blood (2005) 106 (11): 2485.
https://doi.org/10.1182/blood.V106.11.2485.2485
Published: 2005
Journal Articles

In Vivo Drug-Response in Patients with Leukemic Non-Hodgkin’s Lymphomas Is Predicted by In Vitro Chemosensitivity Testing and Gene Expression Profiling.

Kai Uwe Chow, MD, Daniel Nowak, Soo-Zin Kim, MD, Bernd Schneider, Martina Komor, Simone Boehrer, MD, Paris S. Mitrou, MD, Dieter Hoelzer, Eckhart Weidmann, Wolf-Karsten Hofmann
Journal: Blood
Blood (2004) 104 (11): 2273.
https://doi.org/10.1182/blood.V104.11.2273.2273
Published: 2004
Journal Articles

Overexpression of Par-4 Increases TRAIL-Induced Apoptosis in Neoplastic Lymphocytes by Diminishing Expression of Inhibitors-of-Apoptosis-Proteins and by Enforcing Activation of Initiator- and Executionercaspases.

Simone Boehrer, MD, Daniel Nowak, Dieter Hoelzer, MD, Paris S. Mitrou, Kai Uwe Chow
Journal: Blood
Blood (2004) 104 (11): 4329.
https://doi.org/10.1182/blood.V104.11.4329.4329
Published: 2004